Given its pro-inflammatory and immune-regulatory effects, understanding GM-CSF’s role in SSHTN may provide new insights into the mechanisms underlying HTN and aid in the development of new therapeutic options for patients. This evidence concerns the gene CSF2 and hypertensive disorder.